KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Travere Therapeutics (TVTX) Tax Rate (2016 - 2025)

Travere Therapeutics' Tax Rate history spans 12 years, with the latest figure at 4.37% for Q4 2025.

  • For Q4 2025, Tax Rate fell 449.0% year-over-year to 4.37%; the TTM value through Dec 2025 reached 2.01%, down 197.0%, while the annual FY2025 figure was 2.01%, 197.0% down from the prior year.
  • Tax Rate reached 4.37% in Q4 2025 per TVTX's latest filing, down from 0.03% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.15% in Q3 2024 to a low of 4.37% in Q4 2025.
  • Average Tax Rate over 5 years is 0.3%, with a median of 0.08% recorded in 2023.
  • Peak YoY movement for Tax Rate: plummeted -10516bps in 2021, then soared 52bps in 2022.
  • A 5-year view of Tax Rate shows it stood at 0.0% in 2021, then tumbled by -1534bps to 0.07% in 2022, then decreased by -4bps to 0.08% in 2023, then surged by 255bps to 0.12% in 2024, then plummeted by -3764bps to 4.37% in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Tax Rate are 4.37% (Q4 2025), 0.03% (Q3 2025), and 0.16% (Q2 2025).